Paul Hastings Represents Sponsor in Livzon Pharmaceutical’s B to H-share Listing
Paul Hastings, a leading global law firm, announced today that the firm represented Guosen Securities (HK) Capital Company Limited as the sponsor in the listing of Livzon Pharmaceutical Group Inc.’s (“Livzon Pharmaceutical”) H-shares converted from B-shares on the Main Board of the Hong Kong Stock Exchange by way of introduction.
Livzon Pharmaceutical is a comprehensive pharmaceutical enterprise integrating research & development, production and sales of pharmaceutical products and is already listed on the Shenzhen Stock Exchange.